DE3579382D1 - Zyklische amide. - Google Patents

Zyklische amide.

Info

Publication number
DE3579382D1
DE3579382D1 DE8585304196T DE3579382T DE3579382D1 DE 3579382 D1 DE3579382 D1 DE 3579382D1 DE 8585304196 T DE8585304196 T DE 8585304196T DE 3579382 T DE3579382 T DE 3579382T DE 3579382 D1 DE3579382 D1 DE 3579382D1
Authority
DE
Germany
Prior art keywords
cyclic amides
cyclic amide
novel cyclic
galactosemia
indolin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8585304196T
Other languages
English (en)
Inventor
David Robert Brittain
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Application granted granted Critical
Publication of DE3579382D1 publication Critical patent/DE3579382D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C07D453/04—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems having a quinolyl-4, a substituted quinolyl-4 or a alkylenedioxy-quinolyl-4 radical linked through only one carbon atom, attached in position 2, e.g. quinine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE8585304196T 1984-06-19 1985-06-12 Zyklische amide. Expired - Fee Related DE3579382D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848415635A GB8415635D0 (en) 1984-06-19 1984-06-19 Cyclic amides

Publications (1)

Publication Number Publication Date
DE3579382D1 true DE3579382D1 (de) 1990-10-04

Family

ID=10562659

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585304196T Expired - Fee Related DE3579382D1 (de) 1984-06-19 1985-06-12 Zyklische amide.

Country Status (7)

Country Link
EP (1) EP0168181B1 (de)
JP (1) JPS6112689A (de)
AT (1) ATE56013T1 (de)
AU (1) AU4310585A (de)
DE (1) DE3579382D1 (de)
GB (1) GB8415635D0 (de)
ZA (1) ZA854019B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6317886A (ja) * 1986-07-11 1988-01-25 Kyorin Pharmaceut Co Ltd スピロピロリジン−２，５−ジオン誘導体の製法
JPS6317885A (ja) * 1986-07-11 1988-01-25 Kyorin Pharmaceut Co Ltd スピロピロリジン−２，５−ジオン誘導体の製造方法
US4946858A (en) * 1988-10-20 1990-08-07 American Home Products Corporation Novel spirosuccinimides as aldose reductase inhibitors and antihyperglycemic agents
US4900739A (en) * 1988-10-20 1990-02-13 American Home Products Corp. Novel spirosuccinimides as aldose reductase inhibitors and antihyperglycemic agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE53102B1 (en) * 1981-05-12 1988-06-22 Ici Plc Pharmaceutical spiro-succinimide derivatives
GB8331194D0 (en) * 1982-12-20 1983-12-29 Ici Plc Chemical process

Also Published As

Publication number Publication date
ATE56013T1 (de) 1990-09-15
EP0168181B1 (de) 1990-08-29
GB8415635D0 (en) 1984-07-25
AU4310585A (en) 1986-01-02
JPS6112689A (ja) 1986-01-21
EP0168181A1 (de) 1986-01-15
ZA854019B (en) 1986-02-26

Similar Documents

Publication Publication Date Title
DK463989D0 (da) Farmaceutisk virksom kombination
DK543587A (da) Farmaceutisk praeparat stabiliseret mod oxidation
DE68909077T2 (de) Gamma-Linolensäure oder Dihomo-gamma-Linolensäure enthaltende Zubereitung zur Verbesserung der Haut.
NO904378L (no) Fremgangsmaate for fremstilling av et modifisert protein for terapeutisk anvendelse.
EP0283369A3 (en) Use of metformin in the preparation of medicaments
ATE104151T1 (de) Trombosebehandlung mit fibrinolytika und prostacyclinen.
ES2058201T3 (es) Esteres de castanoespermina en el tratamiento de infecciones retrovirales.
DE3888517T2 (de) Verwendung von racemischen Mischungen von Alpha-D-glucopyranosyl-1-6-mannitol und Alpha-D-glucopyranosyl-1-6-sorbitol in zuckerfreien Kaugummizusammensetzungen mit verminderter Feuchtigkeitsaufnahme.
ATE73462T1 (de) Hirudin-variante, deren verwendung und herstellung.
ATE131056T1 (de) Verwendung von 2,3,4,5-tetrahydro-1h-3- benzazepinen bei der behandlung von neurologischen störungen.
NO178546C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive ACE-hemmere med nootrop virkning
DE3579382D1 (de) Zyklische amide.
EP0305890A3 (en) Use of bezafibrate for the treatment of diabetes
IT1240683B (it) Composizione farmaceutica contenente egf
ATE113939T1 (de) Verfahren zur herstellung von cephalosporin und zwischenverbindungen.
ES2044100T3 (es) Ciertas combinaciones de antagonistas del "paf" y antihistaminicos y metodos.
EP0177965A3 (en) Novel oxa- and thiadiazolyl derivatives and their use
EP0293925A3 (en) Compound active in cardiovasular therapy
DK522187D0 (da) Imidozothienopyrimidiner, deres fremstilling og anvendelse
NO890261D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater.
IT1223340B (it) Trattamento disinfestante dei cereali immagazzinati mediante anidride carbonica gassosa
NO881798D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee